A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia
Clinical trial NCT04510298 · COMPLETED
Trial details
- NCT number
- NCT04510298
- Sponsor
- Sirtsei Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2021-04-15
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.